Jason R. Todd

419 total citations
8 papers, 310 citations indexed

About

Jason R. Todd is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jason R. Todd has authored 8 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Jason R. Todd's work include Melanoma and MAPK Pathways (5 papers), Cutaneous Melanoma Detection and Management (4 papers) and Mast cells and histamine (3 papers). Jason R. Todd is often cited by papers focused on Melanoma and MAPK Pathways (5 papers), Cutaneous Melanoma Detection and Management (4 papers) and Mast cells and histamine (3 papers). Jason R. Todd collaborates with scholars based in Australia, United Kingdom and United States. Jason R. Todd's co-authors include Helen Rizos, Richard Kefford, Matteo S. Carlino, Therese M. Becker, Georgina V. Long, Carina Fung, Branka Mijatov, Gulietta M. Pupo, Lyndee L. Scurr and Kavitha Gowrishankar and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.

In The Last Decade

Jason R. Todd

8 papers receiving 310 citations

Peers

Countries citing papers authored by Jason R. Todd

Since Specialization

Citations

This map shows the geographic impact of Jason R. Todd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason R. Todd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason R. Todd more than expected).

Fields of papers citing papers by Jason R. Todd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason R. Todd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason R. Todd. The network helps show where Jason R. Todd may publish in the future.

Co-authorship network of co-authors of Jason R. Todd

This figure shows the co-authorship network connecting the top 25 collaborators of Jason R. Todd. A scholar is included among the top collaborators of Jason R. Todd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason R. Todd. Jason R. Todd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors 2016 ·Cell Reports ·(unknown), Jason R. Todd, Martina Finetti, Frank McCarthy, Malgorzata Broncel, Simon Vyse, (unknown), Stephen Crosier, Karen A. Ryall, (unknown), Leo S. Payne, Frances Daley, Patty T. Wai, Andrew Jenks, B Tanos, Aik Choon Tan, Rachael Natrajan, Daniel Williamson, Paul H. Huang	40
2	Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer 2016 ·Oncotarget ·Jason R. Todd, Karen A. Ryall, Simon Vyse, (unknown), Rachael Natrajan, Yinyin Yuan, Aik Choon Tan, Paul H. Huang	29
3	Preexisting MEK1P124 Mutations Diminish Response to BRAF Inhibitors in Metastatic Melanoma Patients 2014 ·Clinical Cancer Research ·Matteo S. Carlino, Carina Fung, Hamideh Shahheydari, Jason R. Todd, Suzanah C. Boyd, Mal Irvine, Adnan Nagrial, Richard A. Scolyer, Richard Kefford, Georgina V. Long, Helen Rizos	53
4	Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma 2014 ·Molecular Oncology ·Matteo S. Carlino, Jason R. Todd, Kavitha Gowrishankar, Branka Mijatov, Gulietta M. Pupo, Carina Fung, (unknown), Peter Hersey, Georgina V. Long, Richard Kefford, Helen Rizos	90
5	Resistance to c-Kit inhibitors in melanoma: insights for future therapies 2014 ·Oncoscience ·Matteo S. Carlino, Jason R. Todd, Helen Rizos	29
6	Correlation between pre-existing MEK1^P124 mutations and clinical and in vitro response to BRAF inhibitors in metastatic melanoma. 2014 ·Journal of Clinical Oncology ·Matteo S. Carlino, Carina Fung, Hamideh Shahheydari, Jason R. Todd, Richard A. Scolyer, Richard Kefford, Georgina V. Long, Helen Rizos	1
7	Secondary c‐Kit mutations confer acquired resistance to RTK inhibitors in c‐Kit mutant melanoma cells 2013 ·Pigment Cell & Melanoma Research ·Jason R. Todd, Therese M. Becker, Richard Kefford, Helen Rizos	26
8	The MAPK pathway functions as a redundant survival signal that reinforces the PI3K cascade in c-Kit mutant melanoma 2012 ·Oncogene ·Jason R. Todd, Lyndee L. Scurr, Therese M. Becker, Richard Kefford, Helen Rizos	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact